Back to top

Forest Labs Inc: (NYSE: FRX)

(U.S: NYSE) As of Apr 17, 2014 04:00 PM ET

 Add to portfolio

 ZacksTrade Now

$89.58 USD

-0.71 (-0.79%)

Volume: 1,095,921

Zacks Rank : 3-Hold [?]     3    

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1 Strong Buy 26.94%
2 Buy 19.04%
3 Hold 10.56%
4 Sell 4.8%
5 Strong Sell 2.59%
S&P 500 10.39%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The way to access to the Zacks Rank

Company Summary

Forest Laboratories, Inc. and its subsidiaries develop, manufacture and sell both branded and generic forms of ethical drug products which require a physician's prescription, as well as non-prescription pharmaceutical products sold over-the-counter. Forest's most important United States products consist of branded ethical drug specialties marketed directly, or to physicians by the company's Forest Pharmaceuticals, Forest Therapeutics and Forest Specialty Sales salesforces.

General Information

FOREST LABS A

909 THIRD AVENUE

NEW YORK, NY 10022

Phone: 212-421-7850

Fax: 212-750-9152

Web: http://www.frx.com

Email: investor.relations@frx.com

Industry MED-DRUGS
Sector Medical
Fiscal Year End March
Last Reported Quarter 3/31/2014
Next EPS Date 4/29/2014

EPS Information

Current Quarter EPS Consensus Estimate 0.44
Current Year EPS Consensus Estimate 1.34
Estimated Long-Term EPS Growth Rate 37.40
Next EPS Report Date 4/29/2014

Price and Volume Information

Zacks Rank
Yesterday's Close 90.29
52 Week High 100.88
52 Week Low 35.22
Beta 0.73
20 Day Moving Average 3,048,087.50
Target Price Consensus 81.15

FRX

% Price Change
4 Week -6.39
12 Week 32.73
YTD 50.41
% Price Change Relative to S&P 500
4 Week -6.03
12 Week 30.14
YTD 49.28
Share Information
Shares Outstanding (millions) 271.00
Market Capitalization (millions) 24,276.45
Short Ratio 0.37
Last Split Date 1/9/2003
Dividend Information
Dividend Yield 0.00%
Annual Dividend $0.00
Payout Ratio 0.00
Change in Payout Ratio NA
Last Dividend Payout / Amount NA / $0.00

Fundamental Ratios

P/E
P/E (F1) 25.22
Trailing 12 Months 77.22
PEG Ratio 0.67
EPS Growth
vs. Previous Year 228.57%
vs. Previous Quarter -25.00%
   
Sales Growth
vs. Previous Year 21.55%
vs. Previous Quarter 2.71%
   
Price Ratios
Price/Book 4.03
Price/Cash Flow 89.00
Price / Sales 7.16
ROE
3/31/14 NA
12/31/13 5.35
9/30/13 3.19
ROA
3/31/14 NA
12/31/13 3.91
9/30/13 2.42
Current Ratio
3/31/14 NA
12/31/13 4.13
9/30/13 3.02
Quick Ratio
3/31/14 NA
12/31/13 3.71
9/30/13 2.53
Operating Margin
3/31/14 NA
12/31/13 9.25
9/30/13 5.70
Net Margin
3/31/14 NA
12/31/13 4.62
9/30/13 -0.46
Pre-Tax Margin
3/31/14 NA
12/31/13 5.40
9/30/13 -0.73
Book Value
3/31/14 NA
12/31/13 22.25
9/30/13 22.04
Inventory Turnover
3/31/14 NA
12/31/13 1.55
9/30/13 1.53
Debt-to-Equity
3/31/14 NA
12/31/13 0.20
9/30/13 0.00
Debt to Capital
3/31/14 NA
12/31/13 16.68
9/30/13 0.00